TOPICAL TREATMENT OF ERECTILE DYSFUNCTION - RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF CREAM CONTAINING AMINOPHYLLINE, ISOSORBIDE DINITRATE, AND CO-DERGOCRINE MESYLATE

Citation
A. Gomaa et al., TOPICAL TREATMENT OF ERECTILE DYSFUNCTION - RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF CREAM CONTAINING AMINOPHYLLINE, ISOSORBIDE DINITRATE, AND CO-DERGOCRINE MESYLATE, BMJ. British medical journal, 312(7045), 1996, pp. 1512-1515
Citations number
31
Categorie Soggetti
Medicine, General & Internal
ISSN journal
09598138
Volume
312
Issue
7045
Year of publication
1996
Pages
1512 - 1515
Database
ISI
SICI code
0959-8138(1996)312:7045<1512:TTOED->2.0.ZU;2-6
Abstract
Objective-To examine the effectiveness in treating impotence of topica lly applied cream containing three vasodilators-aminophylline, isosorb ide dinitrate, and co-dergocrine mesylate-which act by different mecha nisms. Design-Randomised double blinded placebo controlled crossover t rial over two weeks. Subjects-36 men with erectile dysfunction randoml y allocated to two equal groups. Interventions-Active cream containing aminophylline 3%, isosorbide dinitrate 0.25%, and co-dergocrine mesyl ate 0.05% for one week and placebo for another. Main outcome measures- Patients' reported experience of penile responses and side effects of treatment in questionnaires. Penile tumescence and arterial Row in the laboratory. Results-21 patients reported full erection and satisfacto ry intercourse with the active cream. Three men reported full erection and satisfactory intercourse with either cream. The active cream was more effective in psychogenic than organic impotence (eight out of nin e men with psychogenic impotence achieved a full erection zi four out of eight with neurogenic impotence and two out of seven with arterial insufficiency). No major side effects were reported. In the laboratory the active cream increased penile arterial flow (0.19 (SD 0.08) m/s v 0.02 (0.15) m/s with placebo) and induced tumescence in 24 patients. Conclusions-Topical treatment with a cream containing three different vasodilators might be considered before intracavernous injection of va soactive agents, particularly in psychogenic impotence.